141 related articles for article (PubMed ID: 11836403)
1. trans-Complementation rescue of cyclophilin A-deficient viruses reveals that the requirement for cyclophilin A in human immunodeficiency virus type 1 replication is independent of its isomerase activity.
Saphire AC; Bobardt MD; Gallay PA
J Virol; 2002 Mar; 76(5):2255-62. PubMed ID: 11836403
[TBL] [Abstract][Full Text] [Related]
2. Cyclophilin interactions with incoming human immunodeficiency virus type 1 capsids with opposing effects on infectivity in human cells.
Hatziioannou T; Perez-Caballero D; Cowan S; Bieniasz PD
J Virol; 2005 Jan; 79(1):176-83. PubMed ID: 15596813
[TBL] [Abstract][Full Text] [Related]
3. Target cell cyclophilin A modulates human immunodeficiency virus type 1 infectivity.
Sokolskaja E; Sayah DM; Luban J
J Virol; 2004 Dec; 78(23):12800-8. PubMed ID: 15542632
[TBL] [Abstract][Full Text] [Related]
4. Functional analysis of the secondary HIV-1 capsid binding site in the host protein cyclophilin A.
Peng W; Shi J; Márquez CL; Lau D; Walsh J; Faysal KMR; Byeon CH; Byeon IL; Aiken C; Böcking T
Retrovirology; 2019 Apr; 16(1):10. PubMed ID: 30947724
[TBL] [Abstract][Full Text] [Related]
5. Cyclophilin A and TRIM5alpha independently regulate human immunodeficiency virus type 1 infectivity in human cells.
Sokolskaja E; Berthoux L; Luban J
J Virol; 2006 Mar; 80(6):2855-62. PubMed ID: 16501094
[TBL] [Abstract][Full Text] [Related]
6. Binding of the human immunodeficiency virus type 1 Gag polyprotein to cyclophilin A is mediated by the central region of capsid and requires Gag dimerization.
Colgan J; Yuan HE; Franke EK; Luban J
J Virol; 1996 Jul; 70(7):4299-310. PubMed ID: 8676452
[TBL] [Abstract][Full Text] [Related]
7. The hydrophobic pocket of cyclophilin is the binding site for the human immunodeficiency virus type 1 Gag polyprotein.
Braaten D; Ansari H; Luban J
J Virol; 1997 Mar; 71(3):2107-13. PubMed ID: 9032343
[TBL] [Abstract][Full Text] [Related]
8. A Tripartite Complex HIV-1 Tat-Cyclophilin A-Capsid Protein Enables Tat Encapsidation That Is Required for HIV-1 Infectivity.
Schatz M; Marty L; Ounadjela C; Tong PBV; Cardace I; Mettling C; Milhiet PE; Costa L; Godefroy C; Pugnière M; Guichou JF; Mesnard JM; Blaise M; Beaumelle B
J Virol; 2023 Apr; 97(4):e0027823. PubMed ID: 37129415
[TBL] [Abstract][Full Text] [Related]
9. HIV-1 capsid-cyclophilin interactions determine nuclear import pathway, integration targeting and replication efficiency.
Schaller T; Ocwieja KE; Rasaiyaah J; Price AJ; Brady TL; Roth SL; Hué S; Fletcher AJ; Lee K; KewalRamani VN; Noursadeghi M; Jenner RG; James LC; Bushman FD; Towers GJ
PLoS Pathog; 2011 Dec; 7(12):e1002439. PubMed ID: 22174692
[TBL] [Abstract][Full Text] [Related]
10. Cyclophilin A is required for an early step in the life cycle of human immunodeficiency virus type 1 before the initiation of reverse transcription.
Braaten D; Franke EK; Luban J
J Virol; 1996 Jun; 70(6):3551-60. PubMed ID: 8648689
[TBL] [Abstract][Full Text] [Related]
11. Vif counteracts a cyclophilin A-imposed inhibition of simian immunodeficiency viruses in human cells.
Takeuchi H; Buckler-White A; Goila-Gaur R; Miyagi E; Khan MA; Opi S; Kao S; Sokolskaja E; Pertel T; Luban J; Strebel K
J Virol; 2007 Aug; 81(15):8080-90. PubMed ID: 17522232
[TBL] [Abstract][Full Text] [Related]
12. Cytoplasmic CPSF6 Regulates HIV-1 Capsid Trafficking and Infection in a Cyclophilin A-Dependent Manner.
Zhong Z; Ning J; Boggs EA; Jang S; Wallace C; Telmer C; Bruchez MP; Ahn J; Engelman AN; Zhang P; Watkins SC; Ambrose Z
mBio; 2021 Mar; 12(2):. PubMed ID: 33758083
[TBL] [Abstract][Full Text] [Related]
13. Virion-targeted viral inactivation of human immunodeficiency virus type 1 by using Vpr fusion proteins.
Kobinger GP; Borsetti A; Nie Z; Mercier J; Daniel N; Göttlinger HG; Cohen A
J Virol; 1998 Jul; 72(7):5441-8. PubMed ID: 9620999
[TBL] [Abstract][Full Text] [Related]
14. Cyclophilin A is required for the replication of group M human immunodeficiency virus type 1 (HIV-1) and simian immunodeficiency virus SIV(CPZ)GAB but not group O HIV-1 or other primate immunodeficiency viruses.
Braaten D; Franke EK; Luban J
J Virol; 1996 Jul; 70(7):4220-7. PubMed ID: 8676442
[TBL] [Abstract][Full Text] [Related]
15. Virus specificity and nucleoporin requirements for MX2 activity are affected by GTPase function and capsid-CypA interactions.
Layish B; Goli R; Flick H; Huang SW; Zhang RZ; Kvaratskhelia M; Kane M
PLoS Pathog; 2024 Mar; 20(3):e1011830. PubMed ID: 38512975
[TBL] [Abstract][Full Text] [Related]
16. The cysteine residues of HIV-1 capsid regulate oligomerization and cyclophilin A-induced changes.
Bon Homme M; Carter C; Scarlata S
Biophys J; 2005 Mar; 88(3):2078-88. PubMed ID: 15626706
[TBL] [Abstract][Full Text] [Related]
17. Trim-cyclophilin A fusion proteins can restrict human immunodeficiency virus type 1 infection at two distinct phases in the viral life cycle.
Yap MW; Dodding MP; Stoye JP
J Virol; 2006 Apr; 80(8):4061-7. PubMed ID: 16571822
[TBL] [Abstract][Full Text] [Related]
18. X-ray structure of alisporivir in complex with cyclophilin A at 1.5 Å resolution.
Dujardin M; Bouckaert J; Rucktooa P; Hanoulle X
Acta Crystallogr F Struct Biol Commun; 2018 Sep; 74(Pt 9):583-592. PubMed ID: 30198892
[TBL] [Abstract][Full Text] [Related]
19. Redistribution of cyclophilin A to viral factories during vaccinia virus infection and its incorporation into mature particles.
Castro AP; Carvalho TM; Moussatché N; Damaso CR
J Virol; 2003 Aug; 77(16):9052-68. PubMed ID: 12885921
[TBL] [Abstract][Full Text] [Related]
20. Evolution of cyclophilin A and TRIMCyp retrotransposition in New World primates.
Ribeiro IP; Menezes AN; Moreira MA; Bonvicino CR; Seuánez HN; Soares MA
J Virol; 2005 Dec; 79(23):14998-5003. PubMed ID: 16282502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
